AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39. In the US, Wall Street started trading in a ...

European stocks edged higher Tuesday as a too-close-to-call US presidential election kept traders wary of making big ...

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...

Europe's STOXX 600 eked out minor gains on Tuesday led by gains in industrials as investors assessed a slew of downbeat ...

AstraZeneca has emphasized its continued commitment to delivering medicines in China, despite speculative media reports about ...

Weighing on London, AstraZeneca fell 8.2%, losing its top spot as the most valuable company on the FTSE 100 to oil major Shell in the process. The Cambridge-based pharmaceuticals firm fell back ...

AstraZeneca PLC, maintaining its operations in China, remains steadfast amidst speculative media scrutiny concerning ongoing ...